Medical research

Repairing tendon injuries with stem cells

Tendon tears are rarely life-threatening, but depending on their severity, they require surgery and a long rehabilitation period. Surgical treatment strategies involve the transplantation of tendon from another part of the ...

Genetics

Stopping dementia in Down syndrome patients

Down syndrome is mostly known for the learning disabilities it causes, but patients typically suffer from a wide number of ailments. One is the early onset of Alzheimer's disease. Using iPS cells from Down syndrome patients, ...

Genetics

iPS cells show therapeutic benefits for a rare muscle dystrophy

Muscular dystrophy describes a family of congenital diseases that cause the progressive loss of muscle tissue. Severity varies across the family, but for many there is little in the way of treatment. In its newest study, ...

Oncology & Cancer

Effective new personalized approach for radiation therapy

Researchers from Cleveland Clinic, Case Western Reserve University School of Medicine and Moffitt Cancer Center have found that the genomic adjusted radiation dose (GARD) may be used to personalize radiotherapy (RT) to maximize ...

Alzheimer's disease & dementia

A new model of Alzheimer's progression

Alzheimer's disease is the most common form of dementia and is characterized by neurodegeneration in regions of the brain involved in memory and learning. Amyloid beta and tau are two toxic proteins that build up in disease ...

Medical research

Treating neurological symptoms of CHARGE syndrome

CHARGE syndrome is a rare genetic disorder affecting about 1 in 10,000 newborns. It can lead to neurological and behavioral disorders for which no treatment is currently available. Dr. Kessen Patten and his team from the ...

Medical research

FDA approves immunotherapy for dMMR endometrial cancer

The anti-programmed death receptor 1 (PD-1) monotherapy Jemperli (dostarlimab) received approval for treatment of mismatch repair-deficient (dMMR) recurrent or advanced endometrial cancer that has progressed after treatment ...

Medications

Common Alzheimer's treatment linked to slower cognitive decline

Cholinesterase inhibitors are a group of drugs recommended for the treatment of Alzheimer's disease, but their effects on cognition have been debated and few studies have investigated their long-term effects. A new study ...

Neuroscience

Improving stroke treatment with a modified therapeutic molecule

A research team from the Institut national de la recherche scientifique (INRS) has improved the protective effect of a molecule against ischemic stroke, which is caused by an interruption of blood flow to the brain. The results ...

page 9 from 18